Paul Martin Putora

1 Both heart dose and baseline cardiac risk have been associated with cardiac events after high-dose thoracic RT, and studies are now evaluating the impact of radiation dose on sensitive structures, such as the base of the heart.2-4 However, despite advances in our understanding of these issues, cardiac risk assessment during treatment planning for lung cancer has remained largely simplistic, often focusing on dosimetric values (eg, mean heart dose), which are of limited predictive value in...

Detailed review and results of technical standards Capacity and infrastructure requirements Evidence review The evidence review for this section was limited to papers which covered capacity and infrastructure requirements. Of 138 full texts reviewed, 30 papers were included, alongside two websites [10, 17]. These ranged from single-site pilot/trial data to national protocol/consensus statements.

European Respiratory Journal DOI: 10.1183/13993003.00128-2023 Abstract Screening for lung cancer with low radiation dose computed tomography (LDCT) has a strong evidence base. The European Council adopted a recommendation in November 2022 that lung cancer screening be implemented using a stepwise approach. The imperative now is to ensure that implementation follows an evidence-based process that delivers clinical and cost effectiveness.